Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Exo Therapeutics logo — Advancing precision therapeutics for challenging pharmaceuti...

Exo Therapeutics

Advancing precision therapeutics for challenging pharmaceutical targets through pioneering technology and world-class research.

Founded 2018 11-50 employees Series B Total: $103.00M Biotechnology, Health Care +1

General Information

Company Name Exo Therapeutics
Founded Year 2018
Founders / Decision Makers
Team member
Employees 11-50
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series B
Social

Get notified when Exo Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Exo Therapeutics

Exo Therapeutics, founded in 2018, is a promising biotechnology and pharmaceutical startup that is making waves in the industry with its innovative approach to drug discovery and development. The company's slogan, "Advancing precision therapeutics for challenging pharmaceutical targets through pioneering technology and world-class research," encapsulates its mission to address difficult pharmaceutical targets using cutting-edge technology. Exo Therapeutics' focus on small molecules and its utilization of the proprietary ExoSightTM platform sets it apart in the competitive pharmaceutical landscape. This platform allows the company to create a comprehensive pipeline of highly effective drug candidates that bind to exosites—distinct and distant binding pockets that can reprogram enzyme activity for precise therapeutic outcomes. The company's recent $78.00M Series B investment on 05 October 2021 has attracted significant attention from renowned investors such as CRV, Casdin Capital, Novartis Venture Fund, 6 Dimensions Capital, Newpath Partners, Nextech Invest, Samsara BioCapital, Morningside Venture Investments, and Biotechnology Value Fund. This influx of capital undoubtedly reflects the confidence in Exo Therapeutics' potential to revolutionize the treatment of challenging diseases, including oncology and inflammation. With a team of world-class researchers at the helm, Exo Therapeutics is poised to make substantial strides in developing breakthrough treatments and impacting the biotechnology, health care, and pharmaceutical industries positively. In summary, Exo Therapeutics is a startup with immense potential and a clear vision for pioneering precision therapeutics, making it a compelling prospect for investors seeking opportunities in the rapidly evolving pharmaceutical landscape.

Taxonomy: Precision Therapeutics, Drug Discovery, Small Molecules, ExoSight Platform, Exosites, Enzyme Activity, Oncology, Inflammation, Pharmaceutical Targets, Therapeutic Outcomes, World-class Research, Pioneering Technology, Breakthrough Treatments, Deep Pipeline, Data-driven Research

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 9
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		05 Oct 2021
Series A •••••• 1
Investor
16 Dec 2020

Latest News

View All
C&EN’s 10 Start-Ups to Watch for 2022 — Cen.acs.org
C&EN’s 10 Start-Ups to Watch for 2022
Cen.acs.org Nov 04, 2022

Exo Therapeutics Alternatives & Competitors

Exo Therapeutics vs
Engitix Therapeutics
Engitix Therapeutics United Kingdom

Decoding the ECM space to unlock unprecedented therapies for chronic diseases

Series A
63 employees
Biotechnology, Health Care
Exo Therapeutics vs
SEEDSUPPLY INC.
SEEDSUPPLY INC. Japan

We have the technology to identify seed compounds and target proteins that lead to first in class dr...

Seed
2 employees
Agriculture, Biotechnology
Exo Therapeutics vs
EXO Biologics
EXO Biologics Belgium

Discovering the power of exosomes as future nanomedicines

23 employees
Biopharma, Biotechnology

FAQ About Exo Therapeutics

Advancing precision therapeutics for challenging pharmaceutical targets through pioneering technology and world-class research.
Exo Therapeutics was founded in 2018.
Exo Therapeutics operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Exo Therapeutics has approximately 11-50 employees.
Exo Therapeutics has completed 2 funding rounds, raising a total of $103.00M. The latest funding stage is Series B.
Top alternatives and competitors to Exo Therapeutics include Engitix Therapeutics, SEEDSUPPLY INC., EXO Biologics , Open Targets, InSingulo AB. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Exo Therapeutics and Engitix Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Exo Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy